Ketamine is a really promising kind of chemical that can be the most effective cure for chronic depression – especially given the fact that it was previously shown that this kind of depression occurs most often due to disruption of dendrites and entire neural brain regions. However, experts from the National Institute of Mental Health in the United States today published the results of their recent study on the relationship between ketamine and the potential restoration of neural sections and dendritic bridges between them.
The fact is that dendrites – exactly like the outer membranes of neurons – play an enormous role in the communication between individual neural chains, carrying out additional functions in the form of enrichment of the activity of neurons and blood in the brain. However, previous studies have often demonstrated that impairments – in particular, dendritic processes from the main neurons – lead to the onset and development of systematic depression, which can greatly harm both psychological and physical health.
In this regard, the scientists decided to revert to ketamine as a way to prevent such a neurodegenerative process — and preliminary tests in experimental mice have shown that ketamine can, with a high degree of effectiveness, suspend such a process. In particular, scientists have found that ketamine, when administered in the amount of one standard dose, not only restores the dendritic compounds between neurons, but also exhibits a long-term treatment effect.
This means that in subsequent experiments and trials, ketamine may well become part of any new medicine that is focused on improving brain activity, much the same as it became officially authorized as part of one nasal spray, after the Federal Quality Control Commission The US Food and Drug Administration has approved its use as an auxiliary compound in this spray.